<?xml version="1.0" encoding="UTF-8"?>
<document id="DrugDDI.d130" origId="Tiagabine"><sentence id="DrugDDI.d130.s0" origId="s0" text="In evaluating the potential for interactions among co-administered antiepilepsy drugs (AEDs), whether or not an AED induces or does not induce metabolic enzymes is an important consideration."><entity id="DrugDDI.d130.s0.e0" origId="s0.p4" charOffset="80-85" type="drug" text="drugs"/></sentence><sentence id="DrugDDI.d130.s1" origId="s1" text="Phenytoin, phenobarbital and carbamazepine are ge nerally classified as enzyme inducers;"><entity id="DrugDDI.d130.s1.e0" origId="s1.p20" charOffset="0-9" type="drug" text="Phenytoin"/><entity id="DrugDDI.d130.s1.e1" origId="s1.p21" charOffset="11-24" type="drug" text="phenobarbital"/><entity id="DrugDDI.d130.s1.e2" origId="s1.p23" charOffset="29-42" type="drug" text="carbamazepine"/><pair id="DrugDDI.d130.s1.p0" e1="DrugDDI.d130.s1.e0" e2="DrugDDI.d130.s1.e1" interaction="false"/><pair id="DrugDDI.d130.s1.p1" e1="DrugDDI.d130.s1.e0" e2="DrugDDI.d130.s1.e2" interaction="false"/><pair id="DrugDDI.d130.s1.p2" e1="DrugDDI.d130.s1.e1" e2="DrugDDI.d130.s1.e2" interaction="false"/></sentence><sentence id="DrugDDI.d130.s2" origId="s2" text="valproate and gabapentin are not."><entity id="DrugDDI.d130.s2.e0" origId="s2.p30" charOffset="0-9" type="drug" text="valproate"/><entity id="DrugDDI.d130.s2.e1" origId="s2.p32" charOffset="14-24" type="drug" text="gabapentin"/><pair id="DrugDDI.d130.s2.p0" e1="DrugDDI.d130.s2.e0" e2="DrugDDI.d130.s2.e1" interaction="false"/></sentence><sentence id="DrugDDI.d130.s3" origId="s3" text="GABITRIL is considered to be a non-enzyme inducing AED."><entity id="DrugDDI.d130.s3.e0" origId="s3.p35" charOffset="0-8" type="drug" text="GABITRIL"/></sentence><sentence id="DrugDDI.d130.s4" origId="s4" text="The drug interaction data described in this section were obtained from studies involving either healthy subjects or patients with epilepsy."/><sentence id="DrugDDI.d130.s5" origId="s5" text="Effects of GABITRIL on other Antiepilepsy Drugs (AEDs) : Phenytoin: Tiagabine had no effect on the steady-state plasma concentrations of phenytoin in patients with epilepsy."><entity id="DrugDDI.d130.s5.e0" origId="s5.p54" charOffset="11-19" type="drug" text="GABITRIL"/><entity id="DrugDDI.d130.s5.e1" origId="s5.p55" charOffset="42-47" type="drug" text="Drugs"/><entity id="DrugDDI.d130.s5.e2" origId="s5.p60" charOffset="57-66" type="drug" text="Phenytoin"/><entity id="DrugDDI.d130.s5.e3" origId="s5.p62" charOffset="68-77" type="drug" text="Tiagabine"/><entity id="DrugDDI.d130.s5.e4" origId="s5.p66" charOffset="137-146" type="drug" text="phenytoin"/><pair id="DrugDDI.d130.s5.p0" e1="DrugDDI.d130.s5.e0" e2="DrugDDI.d130.s5.e1" interaction="false"/><pair id="DrugDDI.d130.s5.p1" e1="DrugDDI.d130.s5.e0" e2="DrugDDI.d130.s5.e2" interaction="false"/><pair id="DrugDDI.d130.s5.p2" e1="DrugDDI.d130.s5.e0" e2="DrugDDI.d130.s5.e3" interaction="false"/><pair id="DrugDDI.d130.s5.p3" e1="DrugDDI.d130.s5.e0" e2="DrugDDI.d130.s5.e4" interaction="false"/><pair id="DrugDDI.d130.s5.p4" e1="DrugDDI.d130.s5.e1" e2="DrugDDI.d130.s5.e2" interaction="false"/><pair id="DrugDDI.d130.s5.p5" e1="DrugDDI.d130.s5.e1" e2="DrugDDI.d130.s5.e3" interaction="false"/><pair id="DrugDDI.d130.s5.p6" e1="DrugDDI.d130.s5.e1" e2="DrugDDI.d130.s5.e4" interaction="false"/><pair id="DrugDDI.d130.s5.p7" e1="DrugDDI.d130.s5.e2" e2="DrugDDI.d130.s5.e3" interaction="false"/><pair id="DrugDDI.d130.s5.p8" e1="DrugDDI.d130.s5.e2" e2="DrugDDI.d130.s5.e4" interaction="false"/><pair id="DrugDDI.d130.s5.p9" e1="DrugDDI.d130.s5.e3" e2="DrugDDI.d130.s5.e4" interaction="false"/></sentence><sentence id="DrugDDI.d130.s6" origId="s6" text="Carbamazepine: Tiagabine had no effect on the steady-state plasma concentrations of carbamazepine or its epoxide metabolite in patients with epilepsy."><entity id="DrugDDI.d130.s6.e0" origId="s6.p69" charOffset="0-13" type="drug" text="Carbamazepine"/><entity id="DrugDDI.d130.s6.e1" origId="s6.p71" charOffset="15-24" type="drug" text="Tiagabine"/><entity id="DrugDDI.d130.s6.e2" origId="s6.p75" charOffset="84-97" type="drug" text="carbamazepine"/><entity id="DrugDDI.d130.s6.e3" origId="s6.p77" charOffset="105-123" type="drug" text="epoxide metabolite"/><pair id="DrugDDI.d130.s6.p0" e1="DrugDDI.d130.s6.e0" e2="DrugDDI.d130.s6.e1" interaction="false"/><pair id="DrugDDI.d130.s6.p1" e1="DrugDDI.d130.s6.e0" e2="DrugDDI.d130.s6.e2" interaction="false"/><pair id="DrugDDI.d130.s6.p2" e1="DrugDDI.d130.s6.e0" e2="DrugDDI.d130.s6.e3" interaction="false"/><pair id="DrugDDI.d130.s6.p3" e1="DrugDDI.d130.s6.e1" e2="DrugDDI.d130.s6.e2" interaction="false"/><pair id="DrugDDI.d130.s6.p4" e1="DrugDDI.d130.s6.e1" e2="DrugDDI.d130.s6.e3" interaction="false"/><pair id="DrugDDI.d130.s6.p5" e1="DrugDDI.d130.s6.e2" e2="DrugDDI.d130.s6.e3" interaction="false"/></sentence><sentence id="DrugDDI.d130.s7" origId="s7" text="Valproate: Tiagabine causes a slight decrease (about 10%) in steady-state valproate concentrations."><entity id="DrugDDI.d130.s7.e0" origId="s7.p80" charOffset="0-9" type="drug" text="Valproate"/><entity id="DrugDDI.d130.s7.e1" origId="s7.p82" charOffset="11-20" type="drug" text="Tiagabine"/><entity id="DrugDDI.d130.s7.e2" origId="s7.p88" charOffset="74-83" type="drug" text="valproate"/><pair id="DrugDDI.d130.s7.p0" e1="DrugDDI.d130.s7.e0" e2="DrugDDI.d130.s7.e1" interaction="false"/><pair id="DrugDDI.d130.s7.p1" e1="DrugDDI.d130.s7.e0" e2="DrugDDI.d130.s7.e2" interaction="false"/><pair id="DrugDDI.d130.s7.p2" e1="DrugDDI.d130.s7.e1" e2="DrugDDI.d130.s7.e2" interaction="true"/></sentence><sentence id="DrugDDI.d130.s8" origId="s8" text="Phenobarbital or Primidone : No formal pharmacokinetic studies have been performed examining the addition of tiagabine to regimens containing phenobarbital or primidone."><entity id="DrugDDI.d130.s8.e0" origId="s8.p89" charOffset="0-13" type="drug" text="Phenobarbital"/><entity id="DrugDDI.d130.s8.e1" origId="s8.p91" charOffset="17-26" type="drug" text="Primidone"/><entity id="DrugDDI.d130.s8.e2" origId="s8.p99" charOffset="109-118" type="drug" text="tiagabine"/><entity id="DrugDDI.d130.s8.e3" origId="s8.p102" charOffset="142-155" type="drug" text="phenobarbital"/><entity id="DrugDDI.d130.s8.e4" origId="s8.p104" charOffset="159-168" type="drug" text="primidone"/><pair id="DrugDDI.d130.s8.p0" e1="DrugDDI.d130.s8.e0" e2="DrugDDI.d130.s8.e1" interaction="false"/><pair id="DrugDDI.d130.s8.p1" e1="DrugDDI.d130.s8.e0" e2="DrugDDI.d130.s8.e2" interaction="false"/><pair id="DrugDDI.d130.s8.p2" e1="DrugDDI.d130.s8.e0" e2="DrugDDI.d130.s8.e3" interaction="false"/><pair id="DrugDDI.d130.s8.p3" e1="DrugDDI.d130.s8.e0" e2="DrugDDI.d130.s8.e4" interaction="false"/><pair id="DrugDDI.d130.s8.p4" e1="DrugDDI.d130.s8.e1" e2="DrugDDI.d130.s8.e2" interaction="false"/><pair id="DrugDDI.d130.s8.p5" e1="DrugDDI.d130.s8.e1" e2="DrugDDI.d130.s8.e3" interaction="false"/><pair id="DrugDDI.d130.s8.p6" e1="DrugDDI.d130.s8.e1" e2="DrugDDI.d130.s8.e4" interaction="false"/><pair id="DrugDDI.d130.s8.p7" e1="DrugDDI.d130.s8.e2" e2="DrugDDI.d130.s8.e3" interaction="false"/><pair id="DrugDDI.d130.s8.p8" e1="DrugDDI.d130.s8.e2" e2="DrugDDI.d130.s8.e4" interaction="false"/><pair id="DrugDDI.d130.s8.p9" e1="DrugDDI.d130.s8.e3" e2="DrugDDI.d130.s8.e4" interaction="false"/></sentence><sentence id="DrugDDI.d130.s9" origId="s9" text="The addition of tiagabine in a limited number of patients in three well-controlled studies caused no systematic changes in phenobarbital or primidone concentrations when compared to placebo."><entity id="DrugDDI.d130.s9.e0" origId="s9.p106" charOffset="16-25" type="drug" text="tiagabine"/><entity id="DrugDDI.d130.s9.e1" origId="s9.p112" charOffset="123-136" type="drug" text="phenobarbital"/><entity id="DrugDDI.d130.s9.e2" origId="s9.p114" charOffset="140-149" type="drug" text="primidone"/><pair id="DrugDDI.d130.s9.p0" e1="DrugDDI.d130.s9.e0" e2="DrugDDI.d130.s9.e1" interaction="false"/><pair id="DrugDDI.d130.s9.p1" e1="DrugDDI.d130.s9.e0" e2="DrugDDI.d130.s9.e2" interaction="false"/><pair id="DrugDDI.d130.s9.p2" e1="DrugDDI.d130.s9.e1" e2="DrugDDI.d130.s9.e2" interaction="false"/></sentence><sentence id="DrugDDI.d130.s10" origId="s10" text="Effects of other Antiepilepsy Drugs (AEDs) on GABITRIL : Carbamazepine: Population pharmacokinetic analyses indicate that tiagabine clearance is 60% greater in patients taking carbamazepine with or without other enzyme- inducing AEDs."><entity id="DrugDDI.d130.s10.e0" origId="s10.p119" charOffset="30-35" type="drug" text="Drugs"/><entity id="DrugDDI.d130.s10.e1" origId="s10.p123" charOffset="46-54" type="drug" text="GABITRIL"/><entity id="DrugDDI.d130.s10.e2" origId="s10.p125" charOffset="57-70" type="drug" text="Carbamazepine"/><entity id="DrugDDI.d130.s10.e3" origId="s10.p129" charOffset="122-131" type="drug" text="tiagabine"/><entity id="DrugDDI.d130.s10.e4" origId="s10.p134" charOffset="176-189" type="drug" text="carbamazepine"/><pair id="DrugDDI.d130.s10.p0" e1="DrugDDI.d130.s10.e0" e2="DrugDDI.d130.s10.e1" interaction="false"/><pair id="DrugDDI.d130.s10.p1" e1="DrugDDI.d130.s10.e0" e2="DrugDDI.d130.s10.e2" interaction="false"/><pair id="DrugDDI.d130.s10.p2" e1="DrugDDI.d130.s10.e0" e2="DrugDDI.d130.s10.e3" interaction="false"/><pair id="DrugDDI.d130.s10.p3" e1="DrugDDI.d130.s10.e0" e2="DrugDDI.d130.s10.e4" interaction="false"/><pair id="DrugDDI.d130.s10.p4" e1="DrugDDI.d130.s10.e1" e2="DrugDDI.d130.s10.e2" interaction="false"/><pair id="DrugDDI.d130.s10.p5" e1="DrugDDI.d130.s10.e1" e2="DrugDDI.d130.s10.e3" interaction="false"/><pair id="DrugDDI.d130.s10.p6" e1="DrugDDI.d130.s10.e1" e2="DrugDDI.d130.s10.e4" interaction="false"/><pair id="DrugDDI.d130.s10.p7" e1="DrugDDI.d130.s10.e2" e2="DrugDDI.d130.s10.e3" interaction="false"/><pair id="DrugDDI.d130.s10.p8" e1="DrugDDI.d130.s10.e2" e2="DrugDDI.d130.s10.e4" interaction="false"/><pair id="DrugDDI.d130.s10.p9" e1="DrugDDI.d130.s10.e3" e2="DrugDDI.d130.s10.e4" interaction="true"/></sentence><sentence id="DrugDDI.d130.s11" origId="s11" text="Phenytoin: Population pharmacokinetic analyses indicate that tiagabine clearance is 60% greater in patients taking phenytoin with or without other enzyme- inducing AEDs."><entity id="DrugDDI.d130.s11.e0" origId="s11.p138" charOffset="0-9" type="drug" text="Phenytoin"/><entity id="DrugDDI.d130.s11.e1" origId="s11.p142" charOffset="61-70" type="drug" text="tiagabine"/><entity id="DrugDDI.d130.s11.e2" origId="s11.p147" charOffset="115-124" type="drug" text="phenytoin"/><pair id="DrugDDI.d130.s11.p0" e1="DrugDDI.d130.s11.e0" e2="DrugDDI.d130.s11.e1" interaction="false"/><pair id="DrugDDI.d130.s11.p1" e1="DrugDDI.d130.s11.e0" e2="DrugDDI.d130.s11.e2" interaction="false"/><pair id="DrugDDI.d130.s11.p2" e1="DrugDDI.d130.s11.e1" e2="DrugDDI.d130.s11.e2" interaction="true"/></sentence><sentence id="DrugDDI.d130.s12" origId="s12" text="Phenobarbital (Primidone): Population pharmacokinetic analyses indicate that tiagabine clearance is 60% greater in patients taking phenobarbital (primidone) with or without other enzyme-inducing AEDs."><entity id="DrugDDI.d130.s12.e0" origId="s12.p151" charOffset="0-13" type="drug" text="Phenobarbital"/><entity id="DrugDDI.d130.s12.e1" origId="s12.p153" charOffset="15-24" type="drug" text="Primidone"/><entity id="DrugDDI.d130.s12.e2" origId="s12.p158" charOffset="77-86" type="drug" text="tiagabine"/><entity id="DrugDDI.d130.s12.e3" origId="s12.p163" charOffset="131-144" type="drug" text="phenobarbital"/><entity id="DrugDDI.d130.s12.e4" origId="s12.p165" charOffset="146-155" type="drug" text="primidone"/><pair id="DrugDDI.d130.s12.p0" e1="DrugDDI.d130.s12.e0" e2="DrugDDI.d130.s12.e1" interaction="false"/><pair id="DrugDDI.d130.s12.p1" e1="DrugDDI.d130.s12.e0" e2="DrugDDI.d130.s12.e2" interaction="false"/><pair id="DrugDDI.d130.s12.p2" e1="DrugDDI.d130.s12.e0" e2="DrugDDI.d130.s12.e3" interaction="false"/><pair id="DrugDDI.d130.s12.p3" e1="DrugDDI.d130.s12.e0" e2="DrugDDI.d130.s12.e4" interaction="false"/><pair id="DrugDDI.d130.s12.p4" e1="DrugDDI.d130.s12.e1" e2="DrugDDI.d130.s12.e2" interaction="false"/><pair id="DrugDDI.d130.s12.p5" e1="DrugDDI.d130.s12.e1" e2="DrugDDI.d130.s12.e3" interaction="false"/><pair id="DrugDDI.d130.s12.p6" e1="DrugDDI.d130.s12.e1" e2="DrugDDI.d130.s12.e4" interaction="false"/><pair id="DrugDDI.d130.s12.p7" e1="DrugDDI.d130.s12.e2" e2="DrugDDI.d130.s12.e3" interaction="true"/><pair id="DrugDDI.d130.s12.p8" e1="DrugDDI.d130.s12.e2" e2="DrugDDI.d130.s12.e4" interaction="true"/><pair id="DrugDDI.d130.s12.p9" e1="DrugDDI.d130.s12.e3" e2="DrugDDI.d130.s12.e4" interaction="false"/></sentence><sentence id="DrugDDI.d130.s13" origId="s13" text="Valproate: The addition of tiagabine to patients taking valproate chronically had no effect on tiagabine pharmacokinetics, but valproate significantly decreased tiagabine binding in vitro from 96.3 to 94.8%, which resulted in an increase of approximately 40% in the free tiagabine concentration."><entity id="DrugDDI.d130.s13.e0" origId="s13.p170" charOffset="0-9" type="drug" text="Valproate"/><entity id="DrugDDI.d130.s13.e1" origId="s13.p173" charOffset="27-36" type="drug" text="tiagabine"/><entity id="DrugDDI.d130.s13.e2" origId="s13.p176" charOffset="56-65" type="drug" text="valproate"/><entity id="DrugDDI.d130.s13.e3" origId="s13.p179" charOffset="95-104" type="drug" text="tiagabine"/><entity id="DrugDDI.d130.s13.e4" origId="s13.p181" charOffset="127-136" type="drug" text="valproate"/><entity id="DrugDDI.d130.s13.e5" origId="s13.p188" charOffset="271-280" type="drug" text="tiagabine"/><pair id="DrugDDI.d130.s13.p0" e1="DrugDDI.d130.s13.e0" e2="DrugDDI.d130.s13.e1" interaction="false"/><pair id="DrugDDI.d130.s13.p1" e1="DrugDDI.d130.s13.e0" e2="DrugDDI.d130.s13.e2" interaction="false"/><pair id="DrugDDI.d130.s13.p2" e1="DrugDDI.d130.s13.e0" e2="DrugDDI.d130.s13.e3" interaction="false"/><pair id="DrugDDI.d130.s13.p3" e1="DrugDDI.d130.s13.e0" e2="DrugDDI.d130.s13.e4" interaction="false"/><pair id="DrugDDI.d130.s13.p4" e1="DrugDDI.d130.s13.e0" e2="DrugDDI.d130.s13.e5" interaction="false"/><pair id="DrugDDI.d130.s13.p5" e1="DrugDDI.d130.s13.e1" e2="DrugDDI.d130.s13.e2" interaction="false"/><pair id="DrugDDI.d130.s13.p6" e1="DrugDDI.d130.s13.e1" e2="DrugDDI.d130.s13.e3" interaction="false"/><pair id="DrugDDI.d130.s13.p7" e1="DrugDDI.d130.s13.e1" e2="DrugDDI.d130.s13.e4" interaction="false"/><pair id="DrugDDI.d130.s13.p8" e1="DrugDDI.d130.s13.e1" e2="DrugDDI.d130.s13.e5" interaction="false"/><pair id="DrugDDI.d130.s13.p9" e1="DrugDDI.d130.s13.e2" e2="DrugDDI.d130.s13.e3" interaction="false"/><pair id="DrugDDI.d130.s13.p10" e1="DrugDDI.d130.s13.e2" e2="DrugDDI.d130.s13.e4" interaction="false"/><pair id="DrugDDI.d130.s13.p11" e1="DrugDDI.d130.s13.e2" e2="DrugDDI.d130.s13.e5" interaction="false"/><pair id="DrugDDI.d130.s13.p12" e1="DrugDDI.d130.s13.e3" e2="DrugDDI.d130.s13.e4" interaction="false"/><pair id="DrugDDI.d130.s13.p13" e1="DrugDDI.d130.s13.e3" e2="DrugDDI.d130.s13.e5" interaction="false"/><pair id="DrugDDI.d130.s13.p14" e1="DrugDDI.d130.s13.e4" e2="DrugDDI.d130.s13.e5" interaction="false"/></sentence><sentence id="DrugDDI.d130.s14" origId="s14" text="The clinical relevance of this in vitro finding is unknown."/><sentence id="DrugDDI.d130.s15" origId="s15" text="Interaction of GABITRIL with Other Drugs : Cimetidine : Co-administration of cimetidine (800 mg/day) to patients taking tiagabine chronically had no effect on tiagabine pharmacokinetics."><entity id="DrugDDI.d130.s15.e0" origId="s15.p194" charOffset="15-23" type="drug" text="GABITRIL"/><entity id="DrugDDI.d130.s15.e1" origId="s15.p195" charOffset="35-40" type="drug" text="Drugs"/><entity id="DrugDDI.d130.s15.e2" origId="s15.p197" charOffset="43-53" type="drug" text="Cimetidine"/><entity id="DrugDDI.d130.s15.e3" origId="s15.p200" charOffset="77-87" type="drug" text="cimetidine"/><entity id="DrugDDI.d130.s15.e4" origId="s15.p207" charOffset="120-129" type="drug" text="tiagabine"/><entity id="DrugDDI.d130.s15.e5" origId="s15.p210" charOffset="159-168" type="drug" text="tiagabine"/><pair id="DrugDDI.d130.s15.p0" e1="DrugDDI.d130.s15.e0" e2="DrugDDI.d130.s15.e1" interaction="false"/><pair id="DrugDDI.d130.s15.p1" e1="DrugDDI.d130.s15.e0" e2="DrugDDI.d130.s15.e2" interaction="false"/><pair id="DrugDDI.d130.s15.p2" e1="DrugDDI.d130.s15.e0" e2="DrugDDI.d130.s15.e3" interaction="false"/><pair id="DrugDDI.d130.s15.p3" e1="DrugDDI.d130.s15.e0" e2="DrugDDI.d130.s15.e4" interaction="false"/><pair id="DrugDDI.d130.s15.p4" e1="DrugDDI.d130.s15.e0" e2="DrugDDI.d130.s15.e5" interaction="false"/><pair id="DrugDDI.d130.s15.p5" e1="DrugDDI.d130.s15.e1" e2="DrugDDI.d130.s15.e2" interaction="false"/><pair id="DrugDDI.d130.s15.p6" e1="DrugDDI.d130.s15.e1" e2="DrugDDI.d130.s15.e3" interaction="false"/><pair id="DrugDDI.d130.s15.p7" e1="DrugDDI.d130.s15.e1" e2="DrugDDI.d130.s15.e4" interaction="false"/><pair id="DrugDDI.d130.s15.p8" e1="DrugDDI.d130.s15.e1" e2="DrugDDI.d130.s15.e5" interaction="false"/><pair id="DrugDDI.d130.s15.p9" e1="DrugDDI.d130.s15.e2" e2="DrugDDI.d130.s15.e3" interaction="false"/><pair id="DrugDDI.d130.s15.p10" e1="DrugDDI.d130.s15.e2" e2="DrugDDI.d130.s15.e4" interaction="false"/><pair id="DrugDDI.d130.s15.p11" e1="DrugDDI.d130.s15.e2" e2="DrugDDI.d130.s15.e5" interaction="false"/><pair id="DrugDDI.d130.s15.p12" e1="DrugDDI.d130.s15.e3" e2="DrugDDI.d130.s15.e4" interaction="false"/><pair id="DrugDDI.d130.s15.p13" e1="DrugDDI.d130.s15.e3" e2="DrugDDI.d130.s15.e5" interaction="false"/><pair id="DrugDDI.d130.s15.p14" e1="DrugDDI.d130.s15.e4" e2="DrugDDI.d130.s15.e5" interaction="false"/></sentence><sentence id="DrugDDI.d130.s16" origId="s16" text="Theophylline: A single 10 mg dose of tiagabine did not affect the pharmacokinetics of theophylline at steady state."><entity id="DrugDDI.d130.s16.e0" origId="s16.p211" charOffset="0-12" type="drug" text="Theophylline"/><entity id="DrugDDI.d130.s16.e1" origId="s16.p214" charOffset="37-46" type="drug" text="tiagabine"/><entity id="DrugDDI.d130.s16.e2" origId="s16.p219" charOffset="86-98" type="drug" text="theophylline"/><pair id="DrugDDI.d130.s16.p0" e1="DrugDDI.d130.s16.e0" e2="DrugDDI.d130.s16.e1" interaction="false"/><pair id="DrugDDI.d130.s16.p1" e1="DrugDDI.d130.s16.e0" e2="DrugDDI.d130.s16.e2" interaction="false"/><pair id="DrugDDI.d130.s16.p2" e1="DrugDDI.d130.s16.e1" e2="DrugDDI.d130.s16.e2" interaction="false"/></sentence><sentence id="DrugDDI.d130.s17" origId="s17" text="Warfarin: No significant differences were observed in the steady-state pharmacokinetics of R-warfarin or S-warfarin with the addition of tiagabine given as a single dose."><entity id="DrugDDI.d130.s17.e0" origId="s17.p221" charOffset="0-8" type="drug" text="Warfarin"/><entity id="DrugDDI.d130.s17.e1" origId="s17.p227" charOffset="93-101" type="drug" text="warfarin"/><entity id="DrugDDI.d130.s17.e2" origId="s17.p229" charOffset="107-115" type="drug" text="warfarin"/><entity id="DrugDDI.d130.s17.e3" origId="s17.p231" charOffset="137-146" type="drug" text="tiagabine"/><pair id="DrugDDI.d130.s17.p0" e1="DrugDDI.d130.s17.e0" e2="DrugDDI.d130.s17.e1" interaction="false"/><pair id="DrugDDI.d130.s17.p1" e1="DrugDDI.d130.s17.e0" e2="DrugDDI.d130.s17.e2" interaction="false"/><pair id="DrugDDI.d130.s17.p2" e1="DrugDDI.d130.s17.e0" e2="DrugDDI.d130.s17.e3" interaction="false"/><pair id="DrugDDI.d130.s17.p3" e1="DrugDDI.d130.s17.e1" e2="DrugDDI.d130.s17.e2" interaction="false"/><pair id="DrugDDI.d130.s17.p4" e1="DrugDDI.d130.s17.e1" e2="DrugDDI.d130.s17.e3" interaction="false"/><pair id="DrugDDI.d130.s17.p5" e1="DrugDDI.d130.s17.e2" e2="DrugDDI.d130.s17.e3" interaction="false"/></sentence><sentence id="DrugDDI.d130.s18" origId="s18" text="Prothrombin times were not affected by tiagabine."><entity id="DrugDDI.d130.s18.e0" origId="s18.p238" charOffset="39-48" type="drug" text="tiagabine"/></sentence><sentence id="DrugDDI.d130.s19" origId="s19" text="Digoxin: Concomitant administration of tiagabine did not affect the steady-state pharmacokinetics of digoxin or the mean daily trough serum level of digoxin."><entity id="DrugDDI.d130.s19.e0" origId="s19.p239" charOffset="0-7" type="drug" text="Digoxin"/><entity id="DrugDDI.d130.s19.e1" origId="s19.p242" charOffset="39-48" type="drug" text="tiagabine"/><entity id="DrugDDI.d130.s19.e2" origId="s19.p247" charOffset="101-108" type="drug" text="digoxin"/><entity id="DrugDDI.d130.s19.e3" origId="s19.p250" charOffset="149-156" type="drug" text="digoxin"/><pair id="DrugDDI.d130.s19.p0" e1="DrugDDI.d130.s19.e0" e2="DrugDDI.d130.s19.e1" interaction="false"/><pair id="DrugDDI.d130.s19.p1" e1="DrugDDI.d130.s19.e0" e2="DrugDDI.d130.s19.e2" interaction="false"/><pair id="DrugDDI.d130.s19.p2" e1="DrugDDI.d130.s19.e0" e2="DrugDDI.d130.s19.e3" interaction="false"/><pair id="DrugDDI.d130.s19.p3" e1="DrugDDI.d130.s19.e1" e2="DrugDDI.d130.s19.e2" interaction="false"/><pair id="DrugDDI.d130.s19.p4" e1="DrugDDI.d130.s19.e1" e2="DrugDDI.d130.s19.e3" interaction="false"/><pair id="DrugDDI.d130.s19.p5" e1="DrugDDI.d130.s19.e2" e2="DrugDDI.d130.s19.e3" interaction="false"/></sentence><sentence id="DrugDDI.d130.s20" origId="s20" text="Ethanol or Triazolam: No significant differences were observed in the pharmacokinetics of triazolam (0.125 mg) and tiagabine (10 mg) when given together as a single dose."><entity id="DrugDDI.d130.s20.e0" origId="s20.p251" charOffset="0-7" type="drug" text="Ethanol"/><entity id="DrugDDI.d130.s20.e1" origId="s20.p253" charOffset="11-20" type="drug" text="Triazolam"/><entity id="DrugDDI.d130.s20.e2" origId="s20.p259" charOffset="90-99" type="drug" text="triazolam"/><entity id="DrugDDI.d130.s20.e3" origId="s20.p264" charOffset="115-124" type="drug" text="tiagabine"/><pair id="DrugDDI.d130.s20.p0" e1="DrugDDI.d130.s20.e0" e2="DrugDDI.d130.s20.e1" interaction="false"/><pair id="DrugDDI.d130.s20.p1" e1="DrugDDI.d130.s20.e0" e2="DrugDDI.d130.s20.e2" interaction="false"/><pair id="DrugDDI.d130.s20.p2" e1="DrugDDI.d130.s20.e0" e2="DrugDDI.d130.s20.e3" interaction="false"/><pair id="DrugDDI.d130.s20.p3" e1="DrugDDI.d130.s20.e1" e2="DrugDDI.d130.s20.e2" interaction="false"/><pair id="DrugDDI.d130.s20.p4" e1="DrugDDI.d130.s20.e1" e2="DrugDDI.d130.s20.e3" interaction="false"/><pair id="DrugDDI.d130.s20.p5" e1="DrugDDI.d130.s20.e2" e2="DrugDDI.d130.s20.e3" interaction="false"/></sentence><sentence id="DrugDDI.d130.s21" origId="s21" text="The pharmacokinetics of ethanol were not affected by multiple-dose administration of tiagabine."><entity id="DrugDDI.d130.s21.e0" origId="s21.p273" charOffset="24-31" type="drug" text="ethanol"/><entity id="DrugDDI.d130.s21.e1" origId="s21.p278" charOffset="85-94" type="drug" text="tiagabine"/><pair id="DrugDDI.d130.s21.p0" e1="DrugDDI.d130.s21.e0" e2="DrugDDI.d130.s21.e1" interaction="false"/></sentence><sentence id="DrugDDI.d130.s22" origId="s22" text="Tiagabine has shown no clinically important potentiation of the pharmacodynamic effects of triazo lam or alcohol."><entity id="DrugDDI.d130.s22.e0" origId="s22.p279" charOffset="0-9" type="drug" text="Tiagabine"/><entity id="DrugDDI.d130.s22.e1" origId="s22.p286" charOffset="105-112" type="drug" text="alcohol"/><pair id="DrugDDI.d130.s22.p0" e1="DrugDDI.d130.s22.e0" e2="DrugDDI.d130.s22.e1" interaction="false"/></sentence><sentence id="DrugDDI.d130.s23" origId="s23" text="Because of the possible additive effects of drugs that may depress the nervous system, ethanol or triazolam should be used cautiously in combination with tiagabine."><entity id="DrugDDI.d130.s23.e0" origId="s23.p288" charOffset="44-49" type="drug" text="drugs"/><entity id="DrugDDI.d130.s23.e1" origId="s23.p293" charOffset="87-94" type="drug" text="ethanol"/><entity id="DrugDDI.d130.s23.e2" origId="s23.p295" charOffset="98-107" type="drug" text="triazolam"/><entity id="DrugDDI.d130.s23.e3" origId="s23.p301" charOffset="154-163" type="drug" text="tiagabine"/><pair id="DrugDDI.d130.s23.p0" e1="DrugDDI.d130.s23.e0" e2="DrugDDI.d130.s23.e1" interaction="false"/><pair id="DrugDDI.d130.s23.p1" e1="DrugDDI.d130.s23.e0" e2="DrugDDI.d130.s23.e2" interaction="true"/><pair id="DrugDDI.d130.s23.p2" e1="DrugDDI.d130.s23.e0" e2="DrugDDI.d130.s23.e3" interaction="false"/><pair id="DrugDDI.d130.s23.p3" e1="DrugDDI.d130.s23.e1" e2="DrugDDI.d130.s23.e2" interaction="true"/><pair id="DrugDDI.d130.s23.p4" e1="DrugDDI.d130.s23.e1" e2="DrugDDI.d130.s23.e3" interaction="false"/><pair id="DrugDDI.d130.s23.p5" e1="DrugDDI.d130.s23.e2" e2="DrugDDI.d130.s23.e3" interaction="false"/></sentence><sentence id="DrugDDI.d130.s24" origId="s24" text="Oral Contraceptives: Multiple dose administration of tiagabine (8 mg/day monotherapy) did not alter the pharmacokinetics of oral contraceptives in healthy women of childbearing age."><entity id="DrugDDI.d130.s24.e0" origId="s24.p302" charOffset="0-19" type="drug" text="oral contraceptives"/><entity id="DrugDDI.d130.s24.e1" origId="s24.p305" charOffset="53-62" type="drug" text="tiagabine"/><entity id="DrugDDI.d130.s24.e2" origId="s24.p314" charOffset="124-143" type="drug" text="oral contraceptives"/><pair id="DrugDDI.d130.s24.p0" e1="DrugDDI.d130.s24.e0" e2="DrugDDI.d130.s24.e1" interaction="false"/><pair id="DrugDDI.d130.s24.p1" e1="DrugDDI.d130.s24.e0" e2="DrugDDI.d130.s24.e2" interaction="false"/><pair id="DrugDDI.d130.s24.p2" e1="DrugDDI.d130.s24.e1" e2="DrugDDI.d130.s24.e2" interaction="false"/></sentence><sentence id="DrugDDI.d130.s25" origId="s25" text="Antipyrine : Antipyrine pharmacokinetics were not significantly different before and after tiagabine multiple-dose regimens."><entity id="DrugDDI.d130.s25.e0" origId="s25.p317" charOffset="0-10" type="drug" text="Antipyrine"/><entity id="DrugDDI.d130.s25.e1" origId="s25.p319" charOffset="13-23" type="drug" text="Antipyrine"/><entity id="DrugDDI.d130.s25.e2" origId="s25.p324" charOffset="91-100" type="drug" text="tiagabine"/><pair id="DrugDDI.d130.s25.p0" e1="DrugDDI.d130.s25.e0" e2="DrugDDI.d130.s25.e1" interaction="false"/><pair id="DrugDDI.d130.s25.p1" e1="DrugDDI.d130.s25.e0" e2="DrugDDI.d130.s25.e2" interaction="false"/><pair id="DrugDDI.d130.s25.p2" e1="DrugDDI.d130.s25.e1" e2="DrugDDI.d130.s25.e2" interaction="false"/></sentence><sentence id="DrugDDI.d130.s26" origId="s26" text="This indicates that tiagabine does not cause induction or inhibition of the hepatic microsomal enzyme systems responsible for the metabolism of antipyrine."><entity id="DrugDDI.d130.s26.e0" origId="s26.p327" charOffset="20-29" type="drug" text="tiagabine"/><entity id="DrugDDI.d130.s26.e1" origId="s26.p334" charOffset="84-101" type="drug" text="microsomal enzyme"/><entity id="DrugDDI.d130.s26.e2" origId="s26.p336" charOffset="144-154" type="drug" text="antipyrine"/><pair id="DrugDDI.d130.s26.p0" e1="DrugDDI.d130.s26.e0" e2="DrugDDI.d130.s26.e1" interaction="false"/><pair id="DrugDDI.d130.s26.p1" e1="DrugDDI.d130.s26.e0" e2="DrugDDI.d130.s26.e2" interaction="false"/><pair id="DrugDDI.d130.s26.p2" e1="DrugDDI.d130.s26.e1" e2="DrugDDI.d130.s26.e2" interaction="false"/></sentence><sentence id="DrugDDI.d130.s27" origId="s27" text="Interaction of GABITRIL with Highly Protein Bound Drugs: In vitro data showed that tiagabine is 96% bound to human plasma protein and therefore has the potential to interact with other highly protein bound compounds."><entity id="DrugDDI.d130.s27.e0" origId="s27.p338" charOffset="15-23" type="drug" text="GABITRIL"/><entity id="DrugDDI.d130.s27.e1" origId="s27.p339" charOffset="36-43" type="drug" text="Protein"/><entity id="DrugDDI.d130.s27.e2" origId="s27.p343" charOffset="83-92" type="drug" text="tiagabine"/><entity id="DrugDDI.d130.s27.e3" origId="s27.p347" charOffset="115-129" type="drug" text="plasma protein"/><pair id="DrugDDI.d130.s27.p0" e1="DrugDDI.d130.s27.e0" e2="DrugDDI.d130.s27.e1" interaction="false"/><pair id="DrugDDI.d130.s27.p1" e1="DrugDDI.d130.s27.e0" e2="DrugDDI.d130.s27.e2" interaction="false"/><pair id="DrugDDI.d130.s27.p2" e1="DrugDDI.d130.s27.e0" e2="DrugDDI.d130.s27.e3" interaction="false"/><pair id="DrugDDI.d130.s27.p3" e1="DrugDDI.d130.s27.e1" e2="DrugDDI.d130.s27.e2" interaction="false"/><pair id="DrugDDI.d130.s27.p4" e1="DrugDDI.d130.s27.e1" e2="DrugDDI.d130.s27.e3" interaction="false"/><pair id="DrugDDI.d130.s27.p5" e1="DrugDDI.d130.s27.e2" e2="DrugDDI.d130.s27.e3" interaction="false"/></sentence><sentence id="DrugDDI.d130.s28" origId="s28" text="Such an interaction can potentially lead to higher free fractions of either tiagabine or the competing drug."><entity id="DrugDDI.d130.s28.e0" origId="s28.p362" charOffset="76-85" type="drug" text="tiagabine"/><entity id="DrugDDI.d130.s28.e1" origId="s28.p364" charOffset="103-107" type="drug" text="drug"/><pair id="DrugDDI.d130.s28.p0" e1="DrugDDI.d130.s28.e0" e2="DrugDDI.d130.s28.e1" interaction="false"/></sentence></document>